← Portfolio Scout

Portfolio company

Excellergy Therapeutics

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

Deep Tech

About

This biotechnology company develops trifunctional effector cell response inhibitors to treat patients with severe allergic diseases by removing bound antibodies from immune cells.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies